Last updated: December 10, 2024
Sponsor: Exact Sciences Corporation
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cancer
Treatment
Exact Sciences Multicancer Early Detection (MCED) Test
Clinical Study ID
NCT06589310
EXAS 2022-02
Ages 50-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participant age at time of consent is between 50 and 80 years
Agree to receive the Exact Sciences MCED test and follow-up imaging
Willing and able to provide informed consent
Access to a suitable technology and willing to complete surveys electronically
Exclusion
Exclusion Criteria:
- Any invasive tumor (excluding non-melanoma skin cancers) or hematological malignancyin the previous three years or current suspicion of cancer and/or in activetreatment (e.g., chemotherapy, radiation therapy, immunotherapy, and/or surgery
Study Design
Total Participants: 25000
Treatment Group(s): 1
Primary Treatment: Exact Sciences Multicancer Early Detection (MCED) Test
Phase:
Study Start date:
August 01, 2024
Estimated Completion Date:
January 31, 2031
Study Description
Connect with a study center
Endeavor Health
Evanston, Illinois 60201
United StatesActive - Recruiting
Baylor Scott & White Health
Dallas, Texas 75246
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.